Question · Q3 2025
Tom Gallagher inquired about the nature of the $12 billion in Q4 PRT wins (large vs. small deals), the competitive dynamics in the market, and the underlying factors contributing to the improvement in non-medical health, specifically the split between dental and disability, and confidence for Q4.
Answer
Ramy Tadros, President of U.S. Business at MetLife, confirmed the $12 billion in Q4 PRT wins were a few large deals, emphasizing MetLife's competitive advantages in the jumbo market (balance sheet, investment capabilities, track record) and a disciplined M&A approach. For non-medical health, he attributed sequential improvement to favorable seasonal dental utilization and pricing actions, with disability performing well and in line with expectations, expressing confidence in further Q4 improvement due to continued dental seasonality.
Ask follow-up questions
Fintool can predict
MET's earnings beat/miss a week before the call